Navigation Links
American Chemical Society calls green chemistry bill a 'smart step'
Date:9/5/2007

WASHINGTON, D.C., Sept. 5, 2007 The American Chemical Society (ACS) today praised House passage of legislation seeking to improve federal coordination, dissemination and investment in green chemistry research and development (R&D). The Green Chemistry Research and Development Act of 2007 (HR 2850) aims to provide safer, more sustainable technological options to replace traditional products and processes.

H.R. 2850 was introduced in the House on June 25, 2007, by Reps. Phil Gingrey (R-Ga.), Mario Diaz-Balart (R-Fla.), Vernon Ehlers (R-Mich.), Peter Welch (D-Vt.), and David Wu (D-Ore.). On July 11, 2007, the House Committee on Science and Technology passed the bill by unanimous consent, and the bill yesterday passed the full House of Representatives by voice vote. Similar legislation was passed overwhelmingly by the House in each of the last two Congresses, but was not acted on in the Senate.

Green chemistry is the ultimate proof that environmental and economic benefits in chemistry can be optimized simultaneously. The technologies that spin out of this novel research are the seeds that can sustain small business ventures and green corporate practices, said Catherine T. Hunt, Ph.D., ACS President. From reducing and improving pharmaceutical processes, reinventing the home and construction business, to over-coming our climate and energy challenges, green chemistry is proving that economics and environment are not mutually exclusive.

The bill dedicates resources at a number of federal agencies towards green chemistry R&D and improves interagency coordination. By concentrating on sustainable economic practices in the chemical industry, we can move towards a more sustainable vision of the future, Hunt said. In a letter to lead sponsor Gingrey, Hunt praised the interagency program set up by the legislation because it would strengthen the governments role as a true partner in promoting greener technologies.

Under the bill, the Nati
'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert

Page: 1 2

Related biology news :

1. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
2. Health costs soar as 60 million Americans classed as obese
3. Discovery of an American salamander where it shouldnt be: Korea
4. DNA traces evolution of extinct sabertooths and the American cheetah-like cat
5. North & South American researchers find architectural abnormalities in T. cruzi ribosome
6. T-rays: New imaging technology spotlighted by American Chemical Society
7. New peptide antibiotic isolated from American oyster
8. Computers to save unique type of American red squirrel
9. Alcoholism, smoking and genetics among Plains American Indians
10. Gene variation increases SIDS risk in African Americans
11. Americans support free access to research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2015)... GOTHENBURG, Sweden , August 11, 2015 ... sensor FPC1155. Already received as well as expected revenues in 2015 ... included in FPC,s communicated revenue guidance of approximately 2,200 MSEK for ... is a prominent smartphone manufacturer ... ZUK selected FPC1 155 ...
(Date:8/6/2015)... Calif. , Aug. 6, 2015 ... developer of human interface solutions, today announced collaboration ... technologies on Windows 10. Microsoft leveraged Synaptics, deep ... the operating system. Through stringent ... are fully certified with Microsoft,s Precision TouchPad (PTP) ...
(Date:8/4/2015)...  AMRI (NASDAQ: AMRI ) today reported financial and operating ... Highlights: , Second quarter contract revenue of $ ... , Adjusted contract margins of 26 % ... $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial quarter, ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... has comparable efficacy to chemotherapy, and is better ... has progressed quickly after treatment with first-line therapy, ... show. Dr Tudor Ciuleanu from the Institute ... finding from the international TITAN study at the ...
... have found that when growing corn crops for ethanol, more ... edition of the American Chemical Society,s journal Environmental Science ... fertilizer while they improve their production of feedstock for ethanol ... implications for an industry that has grown dramatically in recent ...
... York University,s Clinical and Translational Science Institute (CTSI) has ... grant to assess the feasibility of using gingival crevicular ... a blood glucose measurement -- as a means of ... between New York University,s Langone Medical Center and the ...
Cached Biology News:Erlotinib effective and with fewer side-effects after first-line treatment 2Overfertilizing corn undermines ethanol 2Overfertilizing corn undermines ethanol 3NYU nursing-dental team receives grant to assess effectiveness of A1C diabetes screening technique 2NYU nursing-dental team receives grant to assess effectiveness of A1C diabetes screening technique 3
(Date:8/31/2015)... 31, 2015  US-Australian drug discovery company, Novogen ... confirmed its comprehensive scientific review has identified high ... areas of unmet patient need. Novogen is moving ... projects prior to entering into Phase 1 clinical ... Acting Chief Executive Officer, Iain Ross , ...
(Date:8/31/2015)... Grove, IL (PRWEB) , ... August 31, 2015 ... ... impurities (PGIs), as a high priority in the drug development approval process. Thus, ... , This year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting ...
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/zsgg5n/global_and_usa ) ... USA BioSimilar Market Analysis to 2021" report to ... market will be initiated in September as Sandoz launches ... global market react? Will biosimilars explode into the biologics ... US economy up to $250 billion within the next ...
(Date:8/28/2015)... ... 28, 2015 , ... Riordan-McKenna Institute founders, stem ... that the use of sterile, dehydrated amniotic tissue AlphaPATCHâ„¢ developed by Amniotic ... surgical knee wound. , The case involved a 78-year-old male, who presented with ...
Breaking Biology Technology:Novogen Announces The Outcome Of A Comprehensive Science Review 2Novogen Announces The Outcome Of A Comprehensive Science Review 3Novogen Announces The Outcome Of A Comprehensive Science Review 4Novogen Announces The Outcome Of A Comprehensive Science Review 5Novogen Announces The Outcome Of A Comprehensive Science Review 6Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4
... June 24 The Board of,Directors of Schering-Plough Corporation ... 6.5 cents per common share. Payment will be made ... close of business on Aug.,1, 2008. As of March ... Board of Directors today also declared a quarterly dividend ...
... Sun Pharmaceutical,Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: ... Levitt, Chairman of the Board,of Directors of Taro Pharmaceutical ... Levitt,s letter of June 19, 2008 to Taro,s,shareholders, his ... the Initiating,Motion filed by Taro in the Tel-Aviv District ...
... etiquette tips via live, interactive ... ... a new way for life science post graduates to enhance their skills,and ... a dual-purpose service that,provides employers a chance to meet potential candidates, and ...
Cached Biology Technology:Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 2Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 3Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 4Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 5Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 6Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 7Online Career Tool Offers Live 'Expert Advice' Component 2